This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through country-case studies.
CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions
Updated: Dec 10, 2021
top of page
A framework to support new product introduction in national health systems
bottom of page
Commentaires